Shares of Aspen Aerogels, Inc. (NYSE:ASPN – Get Rating) have earned a consensus recommendation of "Buy" from the nine research firms that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $47.89.
ASPN has been the topic of several research reports. Cowen raised their price objective on shares of Aspen Aerogels to $72.00 in a research report on Thursday, June 9th. Benchmark lowered their target price on shares of Aspen Aerogels to $29.00 in a report on Tuesday, August 9th. B. Riley lowered their target price on shares of Aspen Aerogels from $44.00 to $34.00 in a report on Wednesday, July 27th. Finally, Craig Hallum lowered their target price on shares of Aspen Aerogels from $50.00 to $32.00 and set a "buy" rating on the stock in a report on Thursday, July 7th.
Get
Aspen Aerogels alerts:
Aspen Aerogels Trading Up 2.3 %
Shares of Aspen Aerogels stock opened at $10.38 on Thursday. Aspen Aerogels has a 1 year low of $7.93 and a 1 year high of $65.99. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.76 and a current ratio of 3.00. The company has a market capitalization of $419.78 million, a P/E ratio of -5.16 and a beta of 2.19. The company's fifty day moving average is $12.66 and its two-hundred day moving average is $17.90.
Aspen Aerogels (NYSE:ASPN – Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The construction company reported ($0.68) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.57) by ($0.11). Aspen Aerogels had a negative return on equity of 46.30% and a negative net
margin of 46.41%. The business had revenue of $45.64 million for the quarter, compared to analysts' expectations of $38.64 million. During the same period in the previous year, the business posted ($0.23) earnings per share. Analysts forecast that Aspen Aerogels will post -2.19 earnings per share for the current year.
Institutional Trading of Aspen Aerogels
A number of institutional investors have recently added to or reduced their stakes in ASPN. BNP Paribas Arbitrage SA boosted its holdings in Aspen Aerogels by 86.0% during the fourth quarter. BNP Paribas Arbitrage SA now owns 6,944 shares of the construction company's stock worth $346,000 after buying an additional 3,210 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in Aspen Aerogels during the fourth quarter worth about $258,000. Invesco Ltd. raised its position in Aspen Aerogels by 120.8% during the fourth quarter. Invesco Ltd. now owns 797,432 shares of the construction company's stock worth $39,704,000 after acquiring an additional 436,343 shares during the last quarter. Abbot Financial Management Inc. acquired a new position in Aspen Aerogels during the fourth quarter worth about $281,000. Finally, Walleye Capital LLC acquired a new position in Aspen Aerogels during the fourth quarter worth about $695,000. Hedge funds and other institutional investors own 91.66% of the company's stock.
Aspen Aerogels Company Profile
(Get Rating)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.
Further Reading
- Get a free copy of the StockNews.com research report on Aspen Aerogels (ASPN)
- A Trio of Q3 Winners With Room to Run
- This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
- Can HCA Healthcare Weather the Normalization?
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
